Medical oncologist Dr. Greg Riely, MSKCC, discusses evidence for whether there are clinically significant differences among specific EGFR mutations that should lead to differences in management.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
